Ambrx Biopharma Inc. (NASDAQ:AMAM) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Daniel O’Connor Other companies: DiaMedica Therapeutics Inc. (Director · Since at least Feb 20, 2025); ZyVersa Therapeutics, Inc. (Director · Dec 20, 2021 – Dec 12, 2022 · Past) | President and CEO, Director · Jan 1, 2023 – Mar 7, 2024 · Past |
| Paul V. Maier Other companies: International Stem Cell Corporation (Director · Since at least Jun 9, 2021); Eton Pharmaceuticals, Inc. (Eton Pharmaceutical Audit Committee Chairman · Since at least May 3, 2021) | Director · Jan 1, 2023 – Mar 7, 2024 · Past |
| Sonja Nelson Other companies: Motus GI Holdings, Inc. (Director · Jun 22, 2021 – Mar 5, 2024 · Past); ImmunityBio, Inc. (Chief Financial Officer · Aug 2, 2019 – Jan 12, 2021 · Past) | Chief Financial Officer · Jan 1, 2023 – Mar 7, 2024 · Past |
| Andrew Aromando Other companies: Oncolytics Biotech Inc. (Chief Business Officer · Since at least Jun 30, 2025) | Chief Operating Officer · Apr 28, 2023 – Mar 7, 2024 · Past |
| Margaret Dalesandro Other companies: Skye Bioscience, Inc. (Director · Sep 14, 2021 – Feb 29, 2024 · Past) | Director · Sep 1, 2023 – Mar 7, 2024 · Past |
| Janet Loesberg | Director · Mar 7, 2024 – Mar 7, 2024 · Past |
| Kate Hermans | Director · Jan 1, 2023 – Mar 7, 2024 · Past |
| Xiaowei Chang | Director · Jan 1, 2023 – Jun 7, 2023 · Past |